Orofar Spray (Buccal)
Benzoxonium Chloride, Lidocaine Chlorohydrate
"2mg, 1.5mg/ml"
Novartis Consumer Health SA
| Pack size | 30ml |
|---|---|
| Dispensing mode | P |
| Source | SWITZERLAND |
| Agent | CITY MEDICAL STORE |
| Retail Price | AED |
Available as:
Indications
Orofar Spray (Buccal) is used for:
For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Benzoxonium Chloride, Lidocaine Chlorohydrate :
Mechanism of Action
Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lidocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (Na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place.
Note
Orofar "2mg, 1.5mg/ml" Spray (Buccal) manufactured by Novartis Consumer Health SA. Its generic name is Benzoxonium Chloride, Lidocaine Chlorohydrate. Orofar is availble in United Arab Emirates.
Farmaco UAE drug index information on Orofar Spray (Buccal) is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.